{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T06:27:35Z","timestamp":1772346455754,"version":"3.50.1"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1097\/mph.0000000000000900","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T21:31:05Z","timestamp":1500672665000},"page":"485-485","source":"Crossref","is-referenced-by-count":5,"title":["Thalidomide in Transfusion Dependent Thalassemia: Hope or Hype"],"prefix":"10.1097","volume":"39","author":[{"given":"Manas","family":"Kalra","sequence":"first","affiliation":[{"name":"Indraprastha Apollo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virender K.","family":"Khanna","sequence":"additional","affiliation":[{"name":"Sir Ganga Ram Hospital, New Delhi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Trehan","sequence":"additional","affiliation":[{"name":"Postgraduate institute of medical education and research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Indraprastha Apollo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1182\/blood-2012-10-408021","article-title":"Clinical experience with fetal hemoglobin induction therapy in patients with beta thalassemia","volume":"121","author":"Musallam","year":"2013","journal-title":"Blood"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1182\/blood-2014-08-435768","article-title":"Update on the use of hydroxyurea therapy in sickle cell disease","volume":"124","author":"Wong","year":"2014","journal-title":"Blood"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bcmd.2008.03.001","article-title":"Thalidomide therapy in a patient with thalassemia major","volume":"41","author":"Aguilar-Lopez","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"R4-20230918","first-page":"63","article-title":"Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy","volume":"8","author":"Masera","year":"2010","journal-title":"Blood Transfus"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"E141","DOI":"10.1002\/ajh.24030","article-title":"Dramatic erythroid response to low-dose thalidomide in two patients with transfusion independent thalassemia and severe post-transfusional alloimmune hemolysis","volume":"90","author":"Fozza","year":"2015","journal-title":"Am J Hematol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcmd.2016.01.003","article-title":"The long-term and extensive efficacy of low dose thalidomide in a case of an untransfusable patient with non-transfusion-dependent thalassemia","volume":"57","author":"Ricchi","year":"2016","journal-title":"Blood Cells Mol Dis"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201708000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:05:47Z","timestamp":1695009947000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201708000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000900","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}